About the Authors
- Martin Zalesak
-
* E-mail: zalesakm@trinitypartners.com
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Kevin Francis
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Alex Gedeon
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- John Gillis
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Kyle Hvidsten
-
Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America
- Phyllis Kidder
-
Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America
- Hong Li
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Derek Martyn
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Leslie Orne
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Amanda Smith
-
Affiliation Trinity Partners, LLC, Waltham, Massachusetts, United States of America
- Ann Kwong
-
Current address: InnovaTID, Cambridge, Massachusetts, United States of America
Affiliation Vertex Pharmaceuticals Incorporated, Cambridge, Massachusetts, United States of America
Competing Interests
KH and PK are employees and stock owners of Vertex Pharmaceuticals Incorporated. AK is a former employee of Vertex Pharmaceuticals Incorporated and owned stock and options in the company at the time this research was performed. MZ, KF, AG, JG, HL, DM, LO, AS are all current or former employees of Trinity Partners, LLC, a for-profit healthcare consultancy. MZ received conference travel grants from Vertex Pharmaceuticals Incorporated to present selected portions of the data described in this manuscript. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MZ LO AK. Analyzed the data: MZ KF AG JG HL DM LO AS AK. Contributed reagents/materials/analysis tools: KF JG. Wrote the paper: MZ HL DM LO AK. Critical revision of the manuscript for important intellectual content: MZ KH PK HL DM LO AK. Obtained funding: KH AK.